• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mainz Biomed N.V. - Ordinary Shares (NQ:MYNZ)

0.8441 UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.8441
Bid (Size) 0.7672 (1,000)
Ask (Size) 0.7997 (1,000)
Prev. Close 0.8441
Today's Range 0.8441 - 0.8441
52wk Range 0.5476 - 4.430
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Friday's after hours session: top gainers and losers ↗
March 13, 2026
Via Chartmill
News headline image
Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors
March 11, 2026
Company Also Announces New Name: Quantum Cyber and Change in Nasdaq Ticker symbol 
From Mainz BioMed NV
Via GlobeNewswire

Performance

YTD
-27.2%
-27.2%
1 Month
N/A
N/A
3 Month
-23.3%
-23.3%
6 Month
-45.5%
-45.5%
1 Year
-72.5%
-72.5%

More News

Read More
Top movers in Friday's after hours session ↗
February 27, 2026
Via Chartmill
News headline image
Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness of mRNA Biomarkers in Blood Samples
February 24, 2026
From Mainz BioMed NV
Via GlobeNewswire
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
February 17, 2026
Via Chartmill
News headline image
Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update
February 17, 2026
From Mainz BioMed NV
Via GlobeNewswire
News headline image
Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting
January 14, 2026
From Mainz BioMed NV
Via GlobeNewswire
News headline image
Mainz Biomed Provides Review of 2025 Highlights
January 05, 2026
From Mainz BioMed NV
Via GlobeNewswire
News headline image
2 Small-Cap Biotechs That Could Reward Patient Investors ↗
December 12, 2025
Via MarketBeat
News headline image
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
December 03, 2025
Via Chartmill
News headline image
DoctorBox Adds Mainz Biomed’s ColoAlert(R) to Its Portfolio
December 02, 2025
From Mainz BioMed NV
Via GlobeNewswire
News headline image
Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America
November 18, 2025
From Mainz BioMed NV
Via GlobeNewswire
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
November 13, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
November 13, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
November 13, 2025
Via Benzinga
News headline image
Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025
November 12, 2025
From Mainz BioMed NV
Via GlobeNewswire
News headline image
Mainz Biomed to Attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS)
November 10, 2025
From Mainz BioMed NV
Via GlobeNewswire
News headline image
Mainz Biomed to Attend 2025 Maxim Growth Summit
October 15, 2025
From Mainz BioMed NV
Via GlobeNewswire
News headline image
Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
October 08, 2025
From Mainz BioMed NV
Via GlobeNewswire
News headline image
Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting
September 30, 2025
From Mainz BioMed NV
Via GlobeNewswire
News headline image
Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland
September 23, 2025
From Mainz BioMed NV
Via GlobeNewswire
News headline image
Mainz Biomed Announces Registration of ColoAlert in the United Kingdom
September 02, 2025
From Mainz BioMed NV
Via GlobeNewswire
News headline image
Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®
August 13, 2025
From Mainz BioMed NV
Via GlobeNewswire
News headline image
Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants
August 04, 2025
From Mainz BioMed NV
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
August 01, 2025
Via Benzinga

Frequently Asked Questions

Is Mainz Biomed N.V. - Ordinary Shares publicly traded?
Yes, Mainz Biomed N.V. - Ordinary Shares is publicly traded.
What exchange does Mainz Biomed N.V. - Ordinary Shares trade on?
Mainz Biomed N.V. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Mainz Biomed N.V. - Ordinary Shares?
The ticker symbol for Mainz Biomed N.V. - Ordinary Shares is MYNZ on the Nasdaq Stock Market
What is the current price of Mainz Biomed N.V. - Ordinary Shares?
The current price of Mainz Biomed N.V. - Ordinary Shares is 0.8441
When was Mainz Biomed N.V. - Ordinary Shares last traded?
The last trade of Mainz Biomed N.V. - Ordinary Shares was at 03/11/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap